Related Experiment Video
Updated: Sep 11, 2025

Isolation and Culture Expansion of Tumor-specific Endothelial Cells
Published on: October 14, 2015
Endothelial cell in tumor angiogenesis: Origins, mechanisms, and therapeutic implication
Yulong Han1,2, Binqiang Zhu2, Shu Meng1,2
1State Key Laboratory of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, Guangdong 510120, China.
Abstract:
A hallmark feature of cancer is its capacity to induce the development of new blood vessels. Anti-angiogenic therapies are commonly employed to combat various types of cancer. Despite notable advancements in this field, limited efficacy and resistance remain critical challenges. While anti-angiogenic therapy primarily targets endothelial cells within the abnormal vasculature, the origins of tumor vascular endothelial cells in solid tumors remain a subject of ongoing debate. Unraveling the origins of these endothelial cells is crucial for developing more effective strategies to combat tumor angiogenesis. This review summarizes the latest findings on the origins of endothelial cells in tumor angiogenesis and explores the progress, limitations, and future directions of anti-angiogenic therapy.
Insights
Cancer
Area of Science:
- Oncology and Vascular Biology
Background:
- Cancer's ability to form new blood vessels (angiogenesis) is a key characteristic.
- Anti-angiogenic therapies target tumor vasculature but face challenges like limited efficacy and resistance.
Purpose of the Study:
- To review current knowledge on the origins of endothelial cells in tumor angiogenesis.
- To explore the progress, limitations, and future of anti-angiogenic therapies.
Main Methods:
- Literature review of recent findings on endothelial cell origins in tumor angiogenesis.
- Analysis of anti-angiogenic therapy effectiveness and challenges.
Main Results:
- The origins of tumor vascular endothelial cells are still debated.
- Understanding these origins is vital for improving anti-angiogenic strategies.
Conclusions:
- Further research into endothelial cell origins is needed to enhance anti-angiogenic therapy.
- Overcoming resistance and improving efficacy are key future directions.
More Related Videos
09:03Author Spotlight: Investigating Angiogenesis and Vessel Permeability Through a Modified Matrix Gel Plug Assay
Published on: June 30, 2023
09:03Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells
Published on: November 23, 2014
Related Concept Videos
Mechanism of Angiogenesis
Regulation of Angiogenesis and Blood Supply
The Tumor Microenvironment
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...